GLP-1 medications, such as semaglutide GLP-1 and Ozempic , are highly effective tools for long-term weight management
In fact, the combination of pharmacological and lifestyle interventions may represent the most powerful path forward in the fight against obesity and its related chronic conditions
"This can be from inflammatory conditions like acne or eczema, injury to the skin, hormonal conditions, medications, and sunlight." This is because acne, sunlight, and skin rashes have the potential to stimulate melanocytes the pigment-making cells in the skin to make a surplus of pigment
This results in cell and skin renewal
Starting Dose and Titration Schedule Retatrutide phase 2 used a structured titration: Weeks 1 to 4: 2 mg subcutaneous once weekly Weeks 5 to 8: 4 mg once weekly Weeks 9 to 12: 8 mg once weekly Week 13 onward: 12 mg once weekly (maximum dose) Gastrointestinal adverse events drove dose reductions in 15.7% of participants receiving 12 mg in the phase 2 trial
As GLP-1 receptor agonists become more common in diabetes and weight management, new concerns are emerging around how GLP-1 medications are managed before surgery